AUTOPATH
For providers needing a more consistent method of performing FNA, AutoAspira provides a reusable and affordable alternative that improves the efficacy of the current procedure. Our device removes the human error while augmenting its existing capabilities with multimodal needle agitation to more efficiently collect clinically diagnostic samples.
Cost Effective
Minimally Invasive
Reusable
Increases Sample Cellularity
User Friendly
Deskilling Potential
EX VIVO TISSUE TESTING STUDY
FNA performed with our device prototype yielded samples with significantly higher aspirate cell concentration (p<0.0001) compared to those yielded by manual FNA
CURRENT STANDARD
AUTOPATH PROTOTYPE
QUANTIFICATION OF CELLULARITY USING AutoAspira PROTOTYPE
IN NUMBERS
85+
Stakeholder Interviews
120+
Benchtop Samples Analyzed
100+
Papers Reviewed
WHERE WE REACH
While we are currently focusing on the sub-Saharan Africa region, we are expanding partnerships across North America, South America, and Asia
STAKEHOLDER VALIDATION
“De-skilling FNA is the way to go because lower level health centers that are more accessible do not currently use this technique and do not have the expertise to be able to effectively perform it.”
Pathologist, Mbarara